[Federal Register Volume 74, Number 178 (Wednesday, September 16, 2009)]
[Notices]
[Pages 47595-47596]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-22299]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket Number NIOSH-186]
Request for Information on Glutaraldehyde
AGENCY: National Institute for Occupational Safety and Health (NIOSH)
of the Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of public comment period.
-----------------------------------------------------------------------
SUMMARY: The National Institute for Occupational Safety and Health
(NIOSH) of the Centers for Disease Control and Prevention (CDC) intends
to evaluate the scientific data on glutaraldehyde, and develop
appropriate communication documents, such as a Criteria Document, which
will convey the potential health risks, recommended measures for safe
handling, and establish an updated Recommended Exposure Limit (REL) for
glutaraldehyde. The current NIOSH REL for glutaraldehyde is 0.2 ppm as
a ceiling limit.
NIOSH is requesting information on the following: (1) Published and
unpublished reports and findings from in vitro and in vivo toxicity
studies with glutaraldehyde, (2) information on possible health effects
observed in workers exposed to glutaraldehyde, (3)
[[Page 47596]]
information on workplaces and products in which glutaraldehyde can be
found, (4) description of work tasks and scenarios with a potential for
exposure to glutaraldehyde, (5) workplace exposure data, and (6)
information on control measures (e.g., engineering controls, work
practices, personal protective equipment) that are being used in
workplaces where potential exposures to glutaraldehyde occur.
Public Comment Period: Comments must be received by December 14,
2009.
ADDRESSES: You may submit comments, identified by docket number NIOSH-
186, by any of the following methods:
Mail: NIOSH Docket Office, Robert A. Taft Laboratories,
MS-C34, 4676 Columbia Parkway, Cincinnati, OH 45226.
Facsimile: (513) 533-8285.
E-mail: [email protected].
All information received in response to this notice will be
available for public examination and copying at the NIOSH Docket
Office, 4676 Columbia Parkway, Cincinnati, Ohio 45226. A complete
electronic docket containing all comments submitted will be available
on the NIOSH Web page at http://www.cdc.gov/niosh/docket, and comments
will be available in writing by request. NIOSH includes all comments
received without change in the docket, including any personal
information provided.
FOR FURTHER INFORMATION CONTACT: T.J. Lentz, NIOSH, Robert A. Taft
Laboratories, MS-C32, 4676 Columbia Parkway, Cincinnati, OH 45226,
telephone (513) 533-8260.
SUPPLEMENTARY INFORMATION: Glutaraldehyde is also known as glutaral,
glutardialdehyde, glutaric aldehyde, pentanedial, and 1,5-pentanedione.
It is a colorless, oily liquid with a pungent odor. It is soluble in
water, alcohol, and ether; and is often used in a diluted form ranging
in strength from 1 to 50%. Glutaraldehyde is used as a cold sterilant
to disinfect medical, surgical, and dental equipment. It has also been
used as an antimicrobial in water treatment systems, in leather tanning
agents, in embalming fluids, as a biocide in metalworking fluids, as a
slimicide in paper manufacturing, as a preservative in cosmetics, as a
disinfectant in animal housing, and as a tissue fixative.
Occupational exposure may occur by inhalation and dermal contact.
Glutaraldehyde can act as an irritant of the eyes, nose, and throat;
and can cause contact and/or allergic dermatitis, asthma, and
difficulty breathing. The current REL for glutaraldehyde (0.2 ppm as a
ceiling limit) was adopted on the basis of NIOSH comments to the
Occupational Safety and Health Administration (OSHA) on the Air
Contaminants Standard [54 FR 2329-2984 (1989)]. In 1991, NIOSH
published a Current Intelligence Bulletin on aldehydes [DHHS (NIOSH)
Publication No. 91-112] which classified acetaldehyde and malonaldehyde
as occupational carcinogens and identified glutaraldehyde as a mutagen.
Because the carcinogenic potential of related aldehydes had not been
adequately evaluated, NIOSH recommended that careful consideration be
given to reducing exposures to related aldehydes, including
glutaraldehyde. OSHA has no permissible exposure limit (PEL) for
glutaraldehyde. The American Conference of Governmental Hygienists
(ACGIH) threshold limit value (TLV) for glutaraldehyde is 0.05 ppm as a
ceiling limit. In 2001 NIOSH published a brochure about the
occupational health effects of glutaraldehyde exposure in hospitals
[DHHS (NIOSH) Publication no. 2001-115].
NIOSH seeks to obtain materials, including published and
unpublished reports and research findings, to evaluate the possible
health risks of occupational exposure to glutaraldehyde. Examples of
requested information include, but are not limited to, the following:
(1) Identification of industries or occupations in which exposures
to glutaraldehyde may occur.
(2) Trends in the production and use of glutaraldehyde.
(3) Description of work tasks and scenarios with a potential for
exposure to glutaraldehyde.
(4) Workplace exposure measurement data in various types of
industries and jobs.
(5) Case reports or other health information demonstrating
potential health effects in workers exposed to glutaraldehyde.
(6) Research findings from in vitro and in vivo studies.
(7) Information on controls (e.g., engineering controls, work
practices, PPE) including costs and effectiveness of control measures
being taken to minimize worker exposure to glutaraldehyde.
(8) Educational materials for worker safety and training on the
safe handling of glutaraldehyde.
(9) Data pertaining to the feasibility of establishing a more
protective REL for glutaraldehyde including projected costs of control
strategies considered.
(10) Names of substitute chemicals or processes being used in place
of glutaraldehyde and type of work tasks.
Dated: September 9, 2009.
John Howard,
Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention.
[FR Doc. E9-22299 Filed 9-15-09; 8:45 am]
BILLING CODE 4163-19-P